These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1967718)

  • 1. Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
    Rosenlöf K; Fyhrquist F; Tenhunen R
    Lancet; 1990 Feb; 335(8684):247-9. PubMed ID: 1967718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An effect of aluminum on hemesynthesis--special reference to erythrocyte uroporphyrinogen--1--Synthetase and protoporphyrin].
    Okajima E; Sasaki K; Ohara S; Yosida K; Kaneko Y; Motomiya Y; Hirao Y
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):161-6. PubMed ID: 2051643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
    Piazza V; Galli F; Villa G; Salvadeo A; Battistel V; Barosi G
    Lancet; 1990 Jul; 336(8709):255-6. PubMed ID: 1973809
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure.
    Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C
    Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exogenous erythropoietin on haem synthesis in anaemic patients with rheumatoid arthritis.
    Pettersson T; Rosenlöf K; Laitinen E; Tenhunen R
    Br J Rheumatol; 1994 Jun; 33(6):526-9. PubMed ID: 8205399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in the erythropoiesis of chronic haemodialysis patients with desferrioxamine.
    de la Serna FJ; Praga M; Gilsanz F; Rodicio JL; Ruilope LM; Alcazar JM
    Lancet; 1988 May; 1(8593):1009-11. PubMed ID: 2896866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminium-induced anaemia in haemodialysis patients.
    McGonigle RJ; Parsons V
    Nephron; 1985; 39(1):1-9. PubMed ID: 3969184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin.
    Romero R; Novoa D; Otero S; Alonso MC; Alonso R; Arcocha V; Arza D; Lens XM; Sanchez-Guisande D
    Nephron; 1993; 63(2):164-7. PubMed ID: 8450906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin, aluminium, and anaemia in patients on haemodialysis.
    Zachée P; Boogaerts MA; Lins RL; Daelemans R; Henckens M; De Broe ME
    Lancet; 1990 Apr; 335(8696):1038-9. PubMed ID: 1970090
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin.
    Casati S; Castelnovo C; Campise M; Ponticelli C
    Nephrol Dial Transplant; 1990; 5(6):441-3. PubMed ID: 2122321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cells indices and aluminium toxicity in haemodialysis patients.
    Tielemans C; Kalima L; Collart F; Wens R; Smeyers-Verbeke J; Verbeelen D; Dratwa M
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():395-8. PubMed ID: 3991530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
    Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
    Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activities of delta-aminolaevulinic acid synthase and haem synthase in experimental sideroblastic anaemia. Effect of mitochondrial iron excess on the enzyme activity in peripheral red blood cells.
    Pasanen AV
    Scand J Clin Lab Invest; 1981 Apr; 41(2):159-65. PubMed ID: 7313498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
    Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
    Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium chelation therapy in dialysis patients: evidence for inhibition of haemoglobin synthesis by low levels of aluminium.
    Altmann P; Plowman D; Marsh F; Cunningham J
    Lancet; 1988 May; 1(8593):1012-5. PubMed ID: 2896867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
    Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
    Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.